Compagnie Lombard Odier SCmA’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.79M | Buy |
137,281
+8,090
| +6% | +$223K | 0.05% | 103 |
|
|
2025
Q1 | $3.66M | Buy |
129,191
+8,905
| +7% | +$252K | 0.04% | 118 |
|
|
2024
Q4 | $5M | Sell |
120,286
-8,018
| -6% | -$333K | 0.07% | 96 |
|
|
2024
Q3 | $8.57M | Sell |
128,304
-9,982
| -7% | -$667K | 0.13% | 79 |
|
|
2024
Q2 | $16.4M | Sell |
138,286
-1,049
| -0.8% | -$125K | 0.28% | 62 |
|
|
2024
Q1 | $14.8M | Buy |
139,335
+2,742
| +2% | +$292K | 0.26% | 68 |
|
|
2023
Q4 | $13.6M | Buy |
136,593
+6,616
| +5% | +$658K | 0.25% | 74 |
|
|
2023
Q3 | $13.4M | Buy |
129,977
+8,615
| +7% | +$890K | 0.31% | 63 |
|
|
2023
Q2 | $14.7M | Sell |
121,362
-698
| -0.6% | -$84.8K | 0.41% | 49 |
|
|
2023
Q1 | $18.7M | Buy |
122,060
+1,649
| +1% | +$253K | 0.47% | 52 |
|
|
2022
Q4 | $21.6M | Buy |
120,411
+4,879
| +4% | +$877K | 0.58% | 49 |
|
|
2022
Q3 | $13.7M | Sell |
115,532
-37,754
| -25% | -$4.46M | 0.39% | 51 |
|
|
2022
Q2 | $21.9M | Buy |
153,286
+2,320
| +2% | +$331K | 0.55% | 46 |
|
|
2022
Q1 | $26M | Buy |
150,966
+47,279
| +46% | +$8.14M | 0.55% | 49 |
|
|
2021
Q4 | $26.3M | Buy |
103,687
+14,882
| +17% | +$3.78M | 0.52% | 47 |
|
|
2021
Q3 | $34.2M | Buy |
88,805
+11,361
| +15% | +$4.37M | 0.74% | 38 |
|
|
2021
Q2 | $18.2M | Sell |
77,444
-84,335
| -52% | -$19.8M | 0.4% | 51 |
|
|
2021
Q1 | $21.2M | Buy |
161,779
+137,360
| +563% | +$18M | 0.47% | 47 |
|
|
2020
Q4 | $2.55M | Buy |
24,419
+14,730
| +152% | +$1.54M | 0.07% | 106 |
|
|
2020
Q3 | $686K | Buy |
9,689
+4,800
| +98% | +$340K | 0.02% | 171 |
|
|
2020
Q2 | $314K | Sell |
4,889
-4,150
| -46% | -$267K | 0.01% | 221 |
|
|
2020
Q1 | $271K | Buy |
+9,039
| New | +$271K | 0.01% | 218 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 551 |
|